Jefferies Financial Group Inc. Has $4.46 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Jefferies Financial Group Inc. lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 138.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 48,514 shares of the medical device company's stock after purchasing an additional 28,204 shares during the period. Jefferies Financial Group Inc.'s holdings in Cooper Companies were worth $4,460,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the stock. Price T Rowe Associates Inc. MD lifted its holdings in Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after acquiring an additional 2,957,421 shares during the last quarter. Norges Bank bought a new position in Cooper Companies in the fourth quarter worth about $217,906,000. FMR LLC lifted its holdings in Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after acquiring an additional 1,095,805 shares during the last quarter. Raymond James Financial Inc. bought a new position in Cooper Companies in the fourth quarter worth about $64,826,000. Finally, Victory Capital Management Inc. lifted its holdings in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $11.02 during mid-day trading on Friday, reaching $68.94. 8,291,770 shares of the company traded hands, compared to its average volume of 1,531,454. The Cooper Companies, Inc. has a fifty-two week low of $65.95 and a fifty-two week high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $13.79 billion, a PE ratio of 35.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The stock has a fifty day simple moving average of $79.82 and a 200-day simple moving average of $88.37.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter last year, the business earned $0.85 earnings per share. The business's revenue for the quarter was up 6.3% on a year-over-year basis. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of a number of recent research reports. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Thursday, May 22nd. Piper Sandler restated an "overweight" rating and issued a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a research note on Friday. JPMorgan Chase & Co. restated a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research note on Friday. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Finally, Robert W. Baird dropped their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research note on Friday. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.38.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.